• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源微小RNA-21-5p和人源微小RNA-145-5p的表达:从正常组织到恶性病变——与雌激素及缺氧-血管生成相关通路基因的上下文依赖性关联:一项初步研究

Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes-Context-Dependent Correlation with Estrogen- and Hypoxia-Vascularization-Related Pathways Genes: A Pilot Study.

作者信息

Górecki Mateusz, Żbikowska Aleksandra, Tokłowicz Małgorzata, Sajdak Stefan, Englert-Golon Monika, Andrusiewicz Mirosław

机构信息

Department of Cell Biology, Poznan University of Medical Sciences, Rokietnicka 5D, 60-806 Poznań, Poland.

Cell Biology Research Group, Student Scientific Society, Poznan University of Medical Sciences, Rokietnicka 5E, 60-806 Poznań, Poland.

出版信息

Int J Mol Sci. 2025 May 7;26(9):4461. doi: 10.3390/ijms26094461.

DOI:10.3390/ijms26094461
PMID:40362695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072406/
Abstract

Ovarian cancer (OC) is a severe gynecological malignancy with a high mortality rate among women worldwide. It is often diagnosed at advanced stages due to the lack of effective screening methods. This study investigated the expression patterns of microRNAs (miRNAs) hsa-miR-21-5p and hsa-miR-145-5p as potential OC prognostic and diagnostic biomarkers and their correlation with estrogen-dependent ( & , and ) and hypoxia-neovascularization-induced (, , and ) pathway genes. Tissue samples obtained from twenty patients with confirmed ovarian cancer and twenty controls were analyzed using quantitative polymerase chain reaction (qPCR) to examine miRNA and mRNA levels. The qPCR analysis revealed significantly higher hsa-miR-21-5p and lower hsa-miR-145-5p expression in OC tissues than controls. Moreover, a significant trend was observed in hsa-miR-21-5p and hsa-miR-145-5p expression levels across normal, non-cancerous changes and malignant ovarian tissues. The hsa-miR-21-5p showed better diagnostic potential than hsa-miR-145-5p. We also observed inconsistent correlations in hsa-miR-21-5p and hsa-mir-145-5p and estrogen-related and hypoxia-neovascularization-dependent genes in ovarian cancer across all groups. This suggests that the relationship between these miRNAs and the selected genes is context-specific. Our findings suggest that hsa-miR-21-5p and hsa-miR-145-5p expression levels may be prognostic or diagnostic markers for ovarian cancer patients.

摘要

卵巢癌(OC)是一种严重的妇科恶性肿瘤,在全球女性中死亡率很高。由于缺乏有效的筛查方法,它常常在晚期才被诊断出来。本研究调查了微小RNA(miRNA)hsa-miR-21-5p和hsa-miR-145-5p作为潜在的OC预后和诊断生物标志物的表达模式,以及它们与雌激素依赖性(&、和)和缺氧-新血管生成诱导(、、和)途径基因的相关性。使用定量聚合酶链反应(qPCR)分析从20例确诊卵巢癌患者和20例对照中获得的组织样本,以检测miRNA和mRNA水平。qPCR分析显示,与对照组相比,OC组织中hsa-miR-21-5p表达显著更高,hsa-miR-145-5p表达更低。此外,在正常、非癌性变化和恶性卵巢组织中,观察到hsa-miR-21-5p和hsa-miR-145-5p表达水平有显著趋势。hsa-miR-21-5p显示出比hsa-miR-145-5p更好的诊断潜力。我们还观察到,在所有组中,卵巢癌中hsa-miR-21-5p和hsa-mir-145-5p与雌激素相关和缺氧-新血管生成依赖性基因之间的相关性不一致。这表明这些miRNA与所选基因之间的关系是上下文特异性的。我们的研究结果表明,hsa-miR-21-5p和hsa-miR-145-5p表达水平可能是卵巢癌患者的预后或诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/a3e0071e11d0/ijms-26-04461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/428e54398b11/ijms-26-04461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/768ed079af8c/ijms-26-04461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/a3e0071e11d0/ijms-26-04461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/428e54398b11/ijms-26-04461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/768ed079af8c/ijms-26-04461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/12072406/a3e0071e11d0/ijms-26-04461-g003.jpg

相似文献

1
Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes-Context-Dependent Correlation with Estrogen- and Hypoxia-Vascularization-Related Pathways Genes: A Pilot Study.人源微小RNA-21-5p和人源微小RNA-145-5p的表达:从正常组织到恶性病变——与雌激素及缺氧-血管生成相关通路基因的上下文依赖性关联:一项初步研究
Int J Mol Sci. 2025 May 7;26(9):4461. doi: 10.3390/ijms26094461.
2
A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer.从人类上皮性卵巢癌全基因组微小RNA表达谱中鉴定出的十种微小RNA特征。
PLoS One. 2014 May 9;9(5):e96472. doi: 10.1371/journal.pone.0096472. eCollection 2014.
3
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
4
Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.miR-195-5p 的过表达通过抑制 PSAT1 依赖性 GSK3β/β-catenin 信号通路降低卵巢癌细胞顺铂耐药性和血管生成。
J Transl Med. 2019 Jun 6;17(1):190. doi: 10.1186/s12967-019-1932-1.
5
Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.上皮性卵巢癌中与总生存期相关的整合 microRNA 和 mRNA 特征。
PLoS One. 2021 Jul 28;16(7):e0255142. doi: 10.1371/journal.pone.0255142. eCollection 2021.
6
Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.用于通过逆转录定量聚合酶链反应检测膀胱癌患者血清微小RNA的内参基因的鉴定与验证
Mol Med Rep. 2015 Jul;12(1):615-22. doi: 10.3892/mmr.2015.3428. Epub 2015 Mar 4.
7
Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of miR-188-5p and Promotion of FOXN2 Expression.Hsa_circ_0001741 通过吸附 miR-188-5p 和促进 FOXN2 表达来抑制卵巢癌细胞增殖。
Mol Biotechnol. 2024 Jun;66(6):1477-1483. doi: 10.1007/s12033-023-00773-4. Epub 2023 Jun 15.
8
Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.长非编码 RNA LINC00968 通过降低 hsa-miR-423-5p 水平而上调 PROX1 抑制乳腺癌细胞增殖、迁移和血管生成。
Cell Cycle. 2019 Aug;18(16):1908-1924. doi: 10.1080/15384101.2019.1632641. Epub 2019 Jun 29.
9
miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.miR-96-5p 通过抑制 Cav-1 促进卵巢癌细胞的增殖和迁移。
J Ovarian Res. 2019 Jun 22;12(1):57. doi: 10.1186/s13048-019-0533-1.
10
Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.鉴定血浆 miR-4505、miR-4743-5p 和 miR-4750-3p 作为 2 型糖尿病患者冠心病的新型诊断生物标志物:病例对照研究。
Cardiovasc Diabetol. 2024 Jul 29;23(1):278. doi: 10.1186/s12933-024-02374-0.

本文引用的文献

1
HIF1A, EPAS1, and VEGFA: angiogenesis and hypoxia-related gene expression in endometrium and endometrial epithelial tumors.缺氧诱导因子1α(HIF1A)、内皮 PAS 结构域蛋白1(EPAS1)和血管内皮生长因子 A(VEGFA):子宫内膜及子宫内膜上皮肿瘤中的血管生成与缺氧相关基因表达
J Appl Genet. 2025 Jan 31. doi: 10.1007/s13353-025-00939-7.
2
Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer.miR-145-3p 水平降低促进晚期高级别浆液性卵巢癌的细胞周期进程。
Cells. 2024 Nov 18;13(22):1904. doi: 10.3390/cells13221904.
3
Hypoxia-Inducible Factor 1-Alpha (HIF-1α) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting.
缺氧诱导因子1α(HIF-1α)与癌症:肿瘤缺氧机制及治疗靶点
Cureus. 2024 Oct 2;16(10):e70700. doi: 10.7759/cureus.70700. eCollection 2024 Oct.
4
miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study.miR-21 和 miR-145 作为宫颈癌患者放疗反应的预后生物标志物:一项初步研究。
Int J Mol Sci. 2024 Sep 30;25(19):10545. doi: 10.3390/ijms251910545.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration.表观遗传改变所致结直肠癌的发病机制与生物标志物
Intest Res. 2024 Apr;22(2):131-151. doi: 10.5217/ir.2023.00115. Epub 2024 Feb 1.
7
Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.鉴定高级别浆液性卵巢癌和良性肿瘤患者血浆中稳定表达的 microRNAs。
Mol Biol Rep. 2023 Dec;50(12):10235-10247. doi: 10.1007/s11033-023-08795-6. Epub 2023 Nov 7.
8
Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer.雌激素、雌激素受体与卵巢癌肿瘤微环境。
Int J Mol Sci. 2023 Sep 28;24(19):14673. doi: 10.3390/ijms241914673.
9
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.血管生成信号通路与癌症的抗血管生成治疗。
Signal Transduct Target Ther. 2023 May 11;8(1):198. doi: 10.1038/s41392-023-01460-1.
10
MicroRNA expression profile analysis in human skeletal muscle tissue: Selection of critical reference.人骨骼肌组织中微小RNA表达谱分析:关键参考的选择
Biomed Pharmacother. 2023 Jun;162:114682. doi: 10.1016/j.biopha.2023.114682. Epub 2023 Apr 7.